Answers are grounded in this paper and cite their sources.
Introduction Erectile dysfunction is a major complication of type 2 diabetes mellitus (T2DM). This study aimed to investigate the effect of active vs. sham low-intensity extracorporeal shock wave therapy (Li-ESWT) on erectile dysfunction in T2DM men. Methods Overall, 40 married T2DM men aged 40–50 years with erectile dysfunction were assigned to the study and the control group. Besides a 12-week daily administration of a 5-mg tablet of phosphodiesterase-5 inhibitor (PDE5I) tadalafil in both groups, the control group (n = 20) received sham Li-ESWT, while the study group (n = 20) received 2 active Li-ESWT (on the penile shaft with 1800 pulses and intensity of 0.09 mJ/mm2) sessions weekly for 3 consecutive weeks; then, the procedure was repeated for another 3 consecutive weeks, with a 3-week rest between the 2 procedures. Erectile dysfunction was assessed by the 5-item version of the International Index of Erectile Function (IIEF-5). Baseline, 1-month follow-up, 3-month follow-up, and 6-month follow-up IIEF-5 scores were documented. Results After 1- and 3-month follow-up, there was a significant difference between the active and sham groups in favour of the active Li-ESWT group (p-value of 0.0001 and 0.01, respectively), but there was no significant difference between the groups at 6-month follow-up. Conclusions Li-ESWT can increase the long-term efficacy of PDE5I in T2DM men with erectile dysfunction.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: